MedTrace Logo

Intravesical Antifibrinolytic for Patients With Hematuria and Clot Retention

NCT04555343 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2021-11-05

No results posted yet for this study

Summary

A study looking at the feasibility of doing a full-scale RCT that investigates the use of tranexamic acid intravesically prior to continuous bladder irrigation treatment in the emergency department for urinary retention due to clots.

We want to know:

* patient experience and acceptability of the intervention
* study procedures (recruitment, site appropriateness, staff engagement)
* safety data
* identify resource use

Conditions

Interventions

DRUG

Tranexamic acid

1gm instilled instravesically

Sponsors & Collaborators

  • BC Support Unit

    collaborator OTHER

  • Michael Smith Foundation for Health Research

    collaborator OTHER

  • Fraser Health

    lead OTHER

Principal Investigators

  • Ali Abdalvand, MD · Fraser Health Authority

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2021-09-30
Completion
2021-10-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04555343 on ClinicalTrials.gov